Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Skin Neoplasms × reolysin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Skin Neoplasms 1 Rhabdoid Tumor 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Melanoma 1 Medulloblastoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Nivolumab 12 Ipilimumab 10 pembrolizumab 8 Surveys and Questionnaires 6 Biopsy 6 cemiplimab 5 Radiotherapy 5 Blood Specimen Collection 5 aldesleukin 4 Photochemotherapy 4 Interleukin-2 4 Fluorouracil 4 Educational Status 4 avelumab 3 Vemurafenib 3 Temozolomide 3 Surgical Procedures, Operative 3 Sirolimus 3 Radiation 3 Petrolatum 3 Cyclophosphamide 3 Cetuximab 3 Aminolevulinic Acid 3 trametinib 2 sonidegib 2 fludarabine phosphate 2 fludarabine 2 dabrafenib 2 atezolizumab 2 Vinblastine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03282188 2018-05-04

REO13 Melanoma With of Without GM-CSF

University of Leeds

Phase 1/2 Withdrawn

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡